nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A5—Dactinomycin—testicular cancer	0.192	0.296	CbGbCtD
Dopamine—SLC22A2—Vinblastine—testicular cancer	0.115	0.177	CbGbCtD
Dopamine—SLC22A2—Cisplatin—testicular cancer	0.105	0.162	CbGbCtD
Dopamine—CYP2C19—Ifosfamide—testicular cancer	0.0714	0.11	CbGbCtD
Dopamine—CYP2C9—Ifosfamide—testicular cancer	0.0593	0.0913	CbGbCtD
Dopamine—POU5F1—Transcriptional regulation of pluripotent stem cells—PRDM14—testicular cancer	0.0395	0.266	CbGpPWpGaD
Dopamine—HTR7—vas deferens—testicular cancer	0.0336	0.283	CbGeAlD
Dopamine—CYP1A2—Etoposide—testicular cancer	0.0315	0.0484	CbGbCtD
Dopamine—CYP2C9—Cisplatin—testicular cancer	0.0289	0.0444	CbGbCtD
Dopamine—CYP2D6—Vinblastine—testicular cancer	0.0288	0.0443	CbGbCtD
Dopamine—CYP2D6—Doxorubicin—testicular cancer	0.0177	0.0272	CbGbCtD
Dopamine—POU5F1—Endoderm Differentiation—PRDM14—testicular cancer	0.0154	0.104	CbGpPWpGaD
Dopamine—HTR7—vein—testicular cancer	0.0143	0.12	CbGeAlD
Dopamine—POU5F1—Preimplantation Embryo—DNMT3L—testicular cancer	0.0108	0.073	CbGpPWpGaD
Dopamine—Extravasation—Carboplatin—testicular cancer	0.00738	0.0885	CcSEcCtD
Dopamine—DRD4—testis—testicular cancer	0.0042	0.0353	CbGeAlD
Dopamine—COMT—seminal vesicle—testicular cancer	0.00365	0.0307	CbGeAlD
Dopamine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00362	0.0244	CbGpPWpGaD
Dopamine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00361	0.0243	CbGpPWpGaD
Dopamine—Extravasation—Vinblastine—testicular cancer	0.00348	0.0417	CcSEcCtD
Dopamine—SLC22A3—embryo—testicular cancer	0.00327	0.0275	CbGeAlD
Dopamine—POU5F1—Developmental Biology—PRDM14—testicular cancer	0.00316	0.0213	CbGpPWpGaD
Dopamine—DRD5—female gonad—testicular cancer	0.00312	0.0263	CbGeAlD
Dopamine—SLC22A3—seminal vesicle—testicular cancer	0.00307	0.0258	CbGeAlD
Dopamine—Necrosis—Dactinomycin—testicular cancer	0.00305	0.0365	CcSEcCtD
Dopamine—MAOB—embryo—testicular cancer	0.00302	0.0255	CbGeAlD
Dopamine—Ventricular arrhythmia—Ifosfamide—testicular cancer	0.00296	0.0355	CcSEcCtD
Dopamine—Extravasation—Bleomycin—testicular cancer	0.00294	0.0353	CcSEcCtD
Dopamine—MAOB—seminal vesicle—testicular cancer	0.00284	0.0239	CbGeAlD
Dopamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00282	0.019	CbGpPWpGaD
Dopamine—Necrosis—Ifosfamide—testicular cancer	0.00279	0.0335	CcSEcCtD
Dopamine—Extravasation—Dactinomycin—testicular cancer	0.00274	0.0329	CcSEcCtD
Dopamine—DRD5—G alpha (s) signalling events—INSL3—testicular cancer	0.00272	0.0183	CbGpPWpGaD
Dopamine—COMT—gonad—testicular cancer	0.00264	0.0222	CbGeAlD
Dopamine—DBH—lymph node—testicular cancer	0.00261	0.022	CbGeAlD
Dopamine—MAOA—embryo—testicular cancer	0.00258	0.0217	CbGeAlD
Dopamine—POU5F1—Cardiac Progenitor Differentiation—KIT—testicular cancer	0.00256	0.0172	CbGpPWpGaD
Dopamine—Extravasation—Ifosfamide—testicular cancer	0.00251	0.0301	CcSEcCtD
Dopamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0025	0.0168	CbGpPWpGaD
Dopamine—Cyanosis—Etoposide—testicular cancer	0.00244	0.0293	CcSEcCtD
Dopamine—MAOA—seminal vesicle—testicular cancer	0.00242	0.0204	CbGeAlD
Dopamine—Necrosis—Cisplatin—testicular cancer	0.00241	0.0289	CcSEcCtD
Dopamine—SLC6A4—NRF2 pathway—SLC2A6—testicular cancer	0.00236	0.0159	CbGpPWpGaD
Dopamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00227	0.0153	CbGpPWpGaD
Dopamine—SLC22A5—seminal vesicle—testicular cancer	0.00223	0.0188	CbGeAlD
Dopamine—SLC22A3—gonad—testicular cancer	0.00222	0.0187	CbGeAlD
Dopamine—Necrosis—Etoposide—testicular cancer	0.0022	0.0265	CcSEcCtD
Dopamine—Extravasation—Cisplatin—testicular cancer	0.00216	0.026	CcSEcCtD
Dopamine—COMT—female gonad—testicular cancer	0.00214	0.0181	CbGeAlD
Dopamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00212	0.0143	CbGpPWpGaD
Dopamine—HTR7—G alpha (s) signalling events—INSL3—testicular cancer	0.0021	0.0141	CbGpPWpGaD
Dopamine—SLC6A2—NRF2 pathway—SLC2A6—testicular cancer	0.00203	0.0137	CbGpPWpGaD
Dopamine—Extravasation—Etoposide—testicular cancer	0.00198	0.0238	CcSEcCtD
Dopamine—Azotaemia—Methotrexate—testicular cancer	0.00195	0.0233	CcSEcCtD
Dopamine—COMT—testis—testicular cancer	0.0019	0.016	CbGeAlD
Dopamine—SLC6A2—gonad—testicular cancer	0.0019	0.016	CbGeAlD
Dopamine—Angina pectoris—Vinblastine—testicular cancer	0.00186	0.0223	CcSEcCtD
Dopamine—HTR7—gonad—testicular cancer	0.00183	0.0154	CbGeAlD
Dopamine—DRD1—G alpha (s) signalling events—INSL3—testicular cancer	0.00181	0.0122	CbGpPWpGaD
Dopamine—SLC22A3—female gonad—testicular cancer	0.0018	0.0152	CbGeAlD
Dopamine—SLC6A3—NRF2 pathway—SLC2A6—testicular cancer	0.0018	0.0121	CbGpPWpGaD
Dopamine—COMT—Phase II conjugation—HPGDS—testicular cancer	0.00177	0.0119	CbGpPWpGaD
Dopamine—SLC6A3—testis—testicular cancer	0.0017	0.0143	CbGeAlD
Dopamine—Atrial fibrillation—Ifosfamide—testicular cancer	0.00168	0.0201	CcSEcCtD
Dopamine—MAOB—female gonad—testicular cancer	0.00167	0.014	CbGeAlD
Dopamine—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00165	0.0111	CbGpPWpGaD
Dopamine—SLC22A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00164	0.0111	CbGpPWpGaD
Dopamine—ADRB1—G alpha (s) signalling events—INSL3—testicular cancer	0.00163	0.011	CbGpPWpGaD
Dopamine—SLC22A3—testis—testicular cancer	0.0016	0.0135	CbGeAlD
Dopamine—MAOB—testis—testicular cancer	0.00148	0.0125	CbGeAlD
Dopamine—Cyanosis—Methotrexate—testicular cancer	0.00146	0.0176	CcSEcCtD
Dopamine—MAOA—female gonad—testicular cancer	0.00142	0.012	CbGeAlD
Dopamine—COMT—lymph node—testicular cancer	0.00138	0.0116	CbGeAlD
Dopamine—SLC6A2—testis—testicular cancer	0.00137	0.0115	CbGeAlD
Dopamine—Angina pectoris—Ifosfamide—testicular cancer	0.00134	0.0161	CcSEcCtD
Dopamine—Necrosis—Methotrexate—testicular cancer	0.00132	0.0158	CcSEcCtD
Dopamine—HTR7—testis—testicular cancer	0.00132	0.0111	CbGeAlD
Dopamine—SLC22A5—female gonad—testicular cancer	0.00131	0.011	CbGeAlD
Dopamine—Ventricular arrhythmia—Epirubicin—testicular cancer	0.00131	0.0157	CcSEcCtD
Dopamine—DRD5—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0013	0.00875	CbGpPWpGaD
Dopamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00128	0.00863	CbGpPWpGaD
Dopamine—MAOA—testis—testicular cancer	0.00126	0.0106	CbGeAlD
Dopamine—DRD2—testis—testicular cancer	0.00125	0.0105	CbGeAlD
Dopamine—Necrosis—Epirubicin—testicular cancer	0.00124	0.0148	CcSEcCtD
Dopamine—Ventricular arrhythmia—Doxorubicin—testicular cancer	0.00121	0.0145	CcSEcCtD
Dopamine—Extravasation—Methotrexate—testicular cancer	0.00119	0.0143	CcSEcCtD
Dopamine—SLC22A5—testis—testicular cancer	0.00116	0.00979	CbGeAlD
Dopamine—SLC22A3—lymph node—testicular cancer	0.00116	0.00976	CbGeAlD
Dopamine—Hypertension—Vinblastine—testicular cancer	0.00115	0.0137	CcSEcCtD
Dopamine—Necrosis—Doxorubicin—testicular cancer	0.00114	0.0137	CcSEcCtD
Dopamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00113	0.00765	CbGpPWpGaD
Dopamine—Bradycardia—Ifosfamide—testicular cancer	0.00112	0.0134	CcSEcCtD
Dopamine—Extravasation—Epirubicin—testicular cancer	0.00111	0.0133	CcSEcCtD
Dopamine—MAOB—lymph node—testicular cancer	0.00107	0.00903	CbGeAlD
Dopamine—COMT—Biological oxidations—HPGDS—testicular cancer	0.00104	0.00699	CbGpPWpGaD
Dopamine—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00103	0.00696	CbGpPWpGaD
Dopamine—Extravasation—Doxorubicin—testicular cancer	0.00103	0.0123	CcSEcCtD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.001	0.00674	CbGpPWpGaD
Dopamine—SLC6A2—lymph node—testicular cancer	0.000993	0.00836	CbGeAlD
Dopamine—DRD5—GPCR ligand binding—INSL3—testicular cancer	0.000988	0.00666	CbGpPWpGaD
Dopamine—MAOB—Biological oxidations—HPGDS—testicular cancer	0.000983	0.00663	CbGpPWpGaD
Dopamine—Bradycardia—Cisplatin—testicular cancer	0.000966	0.0116	CcSEcCtD
Dopamine—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000962	0.00649	CbGpPWpGaD
Dopamine—DRD4—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000958	0.00646	CbGpPWpGaD
Dopamine—MAOA—lymph node—testicular cancer	0.000915	0.0077	CbGeAlD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000862	0.00581	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000851	0.00573	CbGpPWpGaD
Dopamine—Palpitations—Ifosfamide—testicular cancer	0.000846	0.0102	CcSEcCtD
Dopamine—CYP2D6—female gonad—testicular cancer	0.000846	0.00712	CbGeAlD
Dopamine—SLC22A5—lymph node—testicular cancer	0.000843	0.00709	CbGeAlD
Dopamine—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000836	0.00564	CbGpPWpGaD
Dopamine—SLC22A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000834	0.00562	CbGpPWpGaD
Dopamine—Hypertension—Ifosfamide—testicular cancer	0.000827	0.00992	CcSEcCtD
Dopamine—Dyspnoea—Bleomycin—testicular cancer	0.000815	0.00978	CcSEcCtD
Dopamine—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000784	0.00529	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000775	0.00522	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—INSL3—testicular cancer	0.000762	0.00514	CbGpPWpGaD
Dopamine—Vomiting—Chlorambucil—testicular cancer	0.000751	0.00901	CcSEcCtD
Dopamine—CYP2D6—testis—testicular cancer	0.00075	0.00632	CbGeAlD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000741	0.005	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—INSL3—testicular cancer	0.000729	0.00492	CbGpPWpGaD
Dopamine—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000715	0.00482	CbGpPWpGaD
Dopamine—Nausea—Chlorambucil—testicular cancer	0.000702	0.00842	CcSEcCtD
Dopamine—Anxiety—Cisplatin—testicular cancer	0.000701	0.0084	CcSEcCtD
Dopamine—Dyspnoea—Ifosfamide—testicular cancer	0.000697	0.00836	CcSEcCtD
Dopamine—Vomiting—Vinblastine—testicular cancer	0.000689	0.00826	CcSEcCtD
Dopamine—Headache—Vinblastine—testicular cancer	0.000678	0.00814	CcSEcCtD
Dopamine—Tachycardia—Cisplatin—testicular cancer	0.000658	0.00789	CcSEcCtD
Dopamine—DRD1—GPCR ligand binding—INSL3—testicular cancer	0.000656	0.00443	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000653	0.0044	CbGpPWpGaD
Dopamine—Hypertension—Etoposide—testicular cancer	0.000653	0.00784	CcSEcCtD
Dopamine—SLC6A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000651	0.00439	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000651	0.00439	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—INSL3—testicular cancer	0.000648	0.00437	CbGpPWpGaD
Dopamine—Nausea—Vinblastine—testicular cancer	0.000643	0.00772	CcSEcCtD
Dopamine—MAOA—Biological oxidations—HPGDS—testicular cancer	0.000617	0.00416	CbGpPWpGaD
Dopamine—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000611	0.00412	CbGpPWpGaD
Dopamine—Tachycardia—Etoposide—testicular cancer	0.000603	0.00723	CcSEcCtD
Dopamine—Dyspnoea—Cisplatin—testicular cancer	0.000601	0.00721	CcSEcCtD
Dopamine—Angina pectoris—Epirubicin—testicular cancer	0.000593	0.00711	CcSEcCtD
Dopamine—ADRB1—GPCR ligand binding—INSL3—testicular cancer	0.00059	0.00398	CbGpPWpGaD
Dopamine—Vomiting—Bleomycin—testicular cancer	0.000582	0.00698	CcSEcCtD
Dopamine—SLC6A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000577	0.00389	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—INSL3—testicular cancer	0.000564	0.00381	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—INSL3—testicular cancer	0.000558	0.00376	CbGpPWpGaD
Dopamine—Dyspnoea—Etoposide—testicular cancer	0.00055	0.0066	CcSEcCtD
Dopamine—Angina pectoris—Doxorubicin—testicular cancer	0.000549	0.00658	CcSEcCtD
Dopamine—Nausea—Bleomycin—testicular cancer	0.000543	0.00652	CcSEcCtD
Dopamine—Vomiting—Dactinomycin—testicular cancer	0.000542	0.00651	CcSEcCtD
Dopamine—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000525	0.00354	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—INSL3—testicular cancer	0.000507	0.00342	CbGpPWpGaD
Dopamine—Nausea—Dactinomycin—testicular cancer	0.000507	0.00608	CcSEcCtD
Dopamine—Vomiting—Ifosfamide—testicular cancer	0.000497	0.00596	CcSEcCtD
Dopamine—Bradycardia—Epirubicin—testicular cancer	0.000496	0.00595	CcSEcCtD
Dopamine—DRD2—GPCR ligand binding—INSL3—testicular cancer	0.000496	0.00334	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000489	0.0033	CbGpPWpGaD
Dopamine—Nausea—Ifosfamide—testicular cancer	0.000464	0.00557	CcSEcCtD
Dopamine—Bradycardia—Doxorubicin—testicular cancer	0.000459	0.0055	CcSEcCtD
Dopamine—HTR7—GPCR downstream signaling—INSL3—testicular cancer	0.00043	0.0029	CbGpPWpGaD
Dopamine—Vomiting—Cisplatin—testicular cancer	0.000428	0.00514	CcSEcCtD
Dopamine—DRD4—GPCR downstream signaling—INSL3—testicular cancer	0.000412	0.00278	CbGpPWpGaD
Dopamine—Nausea—Cisplatin—testicular cancer	0.0004	0.0048	CcSEcCtD
Dopamine—Vomiting—Etoposide—testicular cancer	0.000393	0.00471	CcSEcCtD
Dopamine—HTR7—Signaling by GPCR—INSL3—testicular cancer	0.000391	0.00264	CbGpPWpGaD
Dopamine—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	0.000389	0.00262	CbGpPWpGaD
Dopamine—Headache—Etoposide—testicular cancer	0.000387	0.00464	CcSEcCtD
Dopamine—POU5F1—Developmental Biology—MMP2—testicular cancer	0.00038	0.00256	CbGpPWpGaD
Dopamine—Palpitations—Epirubicin—testicular cancer	0.000375	0.0045	CcSEcCtD
Dopamine—DRD4—Signaling by GPCR—INSL3—testicular cancer	0.000374	0.00252	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—INSL3—testicular cancer	0.000371	0.0025	CbGpPWpGaD
Dopamine—Nausea—Etoposide—testicular cancer	0.000367	0.0044	CcSEcCtD
Dopamine—Hypertension—Epirubicin—testicular cancer	0.000366	0.00439	CcSEcCtD
Dopamine—DRD3—GPCR downstream signaling—INSL3—testicular cancer	0.000366	0.00247	CbGpPWpGaD
Dopamine—Anxiety—Epirubicin—testicular cancer	0.00036	0.00432	CcSEcCtD
Dopamine—DBH—Metabolism—HPGDS—testicular cancer	0.000359	0.00242	CbGpPWpGaD
Dopamine—Palpitations—Doxorubicin—testicular cancer	0.000347	0.00416	CcSEcCtD
Dopamine—Hypertension—Doxorubicin—testicular cancer	0.000339	0.00406	CcSEcCtD
Dopamine—Tachycardia—Epirubicin—testicular cancer	0.000338	0.00405	CcSEcCtD
Dopamine—DRD1—Signaling by GPCR—INSL3—testicular cancer	0.000337	0.00227	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—INSL3—testicular cancer	0.000333	0.00225	CbGpPWpGaD
Dopamine—Anxiety—Doxorubicin—testicular cancer	0.000333	0.00399	CcSEcCtD
Dopamine—DRD3—Signaling by GPCR—INSL3—testicular cancer	0.000332	0.00224	CbGpPWpGaD
Dopamine—Dyspnoea—Methotrexate—testicular cancer	0.00033	0.00396	CcSEcCtD
Dopamine—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	0.000319	0.00215	CbGpPWpGaD
Dopamine—Tachycardia—Doxorubicin—testicular cancer	0.000313	0.00375	CcSEcCtD
Dopamine—Dyspnoea—Epirubicin—testicular cancer	0.000309	0.0037	CcSEcCtD
Dopamine—ADRB1—Signaling by GPCR—INSL3—testicular cancer	0.000303	0.00204	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—INSL3—testicular cancer	0.0003	0.00202	CbGpPWpGaD
Dopamine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	0.000292	0.00197	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—INSL3—testicular cancer	0.00029	0.00195	CbGpPWpGaD
Dopamine—Dyspnoea—Doxorubicin—testicular cancer	0.000285	0.00343	CcSEcCtD
Dopamine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	0.00028	0.00189	CbGpPWpGaD
Dopamine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	0.000268	0.00181	CbGpPWpGaD
Dopamine—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000266	0.00179	CbGpPWpGaD
Dopamine—DBH—Metabolism—STK11—testicular cancer	0.000261	0.00176	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—INSL3—testicular cancer	0.000254	0.00171	CbGpPWpGaD
Dopamine—Vomiting—Methotrexate—testicular cancer	0.000235	0.00282	CcSEcCtD
Dopamine—Headache—Methotrexate—testicular cancer	0.000232	0.00278	CcSEcCtD
Dopamine—HTR7—Signaling Pathways—INSL3—testicular cancer	0.000231	0.00156	CbGpPWpGaD
Dopamine—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000227	0.00153	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—INSL3—testicular cancer	0.000221	0.00149	CbGpPWpGaD
Dopamine—Vomiting—Epirubicin—testicular cancer	0.00022	0.00264	CcSEcCtD
Dopamine—Nausea—Methotrexate—testicular cancer	0.00022	0.00264	CcSEcCtD
Dopamine—Headache—Epirubicin—testicular cancer	0.000217	0.0026	CcSEcCtD
Dopamine—Nausea—Epirubicin—testicular cancer	0.000206	0.00247	CcSEcCtD
Dopamine—Vomiting—Doxorubicin—testicular cancer	0.000204	0.00244	CcSEcCtD
Dopamine—Headache—Doxorubicin—testicular cancer	0.000201	0.00241	CcSEcCtD
Dopamine—DRD1—Signaling Pathways—INSL3—testicular cancer	0.000199	0.00134	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—INSL3—testicular cancer	0.000196	0.00132	CbGpPWpGaD
Dopamine—Nausea—Doxorubicin—testicular cancer	0.00019	0.00228	CcSEcCtD
Dopamine—ADRB1—Signaling Pathways—INSL3—testicular cancer	0.000179	0.00121	CbGpPWpGaD
Dopamine—COMT—Metabolism—HPGDS—testicular cancer	0.000177	0.0012	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—INSL3—testicular cancer	0.000171	0.00115	CbGpPWpGaD
Dopamine—MAOB—Metabolism—HPGDS—testicular cancer	0.000168	0.00113	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—INSL3—testicular cancer	0.00015	0.00101	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—HPGDS—testicular cancer	0.000142	0.000959	CbGpPWpGaD
Dopamine—COMT—Metabolism—STK11—testicular cancer	0.000129	0.000868	CbGpPWpGaD
Dopamine—MAOB—Metabolism—STK11—testicular cancer	0.000122	0.000823	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000112	0.000756	CbGpPWpGaD
Dopamine—MAOA—Metabolism—HPGDS—testicular cancer	0.000105	0.000711	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—STK11—testicular cancer	0.000103	0.000696	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000102	0.000689	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—H2AFZ—testicular cancer	9.59e-05	0.000646	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—STK11—testicular cancer	9.53e-05	0.000643	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—HPGDS—testicular cancer	8.92e-05	0.000601	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KITLG—testicular cancer	8.82e-05	0.000595	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.73e-05	0.000589	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—HPGDS—testicular cancer	8.31e-05	0.00056	CbGpPWpGaD
Dopamine—MAOA—Metabolism—STK11—testicular cancer	7.66e-05	0.000517	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	7.39e-05	0.000498	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STK11—testicular cancer	7.35e-05	0.000495	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—H2AFZ—testicular cancer	7.08e-05	0.000477	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STK11—testicular cancer	7.04e-05	0.000474	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KITLG—testicular cancer	6.8e-05	0.000458	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—FGFR3—testicular cancer	6.55e-05	0.000442	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KITLG—testicular cancer	6.51e-05	0.000439	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—STK11—testicular cancer	6.48e-05	0.000437	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	6.37e-05	0.000429	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STK11—testicular cancer	6.33e-05	0.000427	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	6.29e-05	0.000424	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STK11—testicular cancer	6.25e-05	0.000421	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—STK11—testicular cancer	6.04e-05	0.000407	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KIT—testicular cancer	6.02e-05	0.000406	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KITLG—testicular cancer	5.86e-05	0.000395	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KITLG—testicular cancer	5.78e-05	0.00039	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—H2AFZ—testicular cancer	5.73e-05	0.000386	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STK11—testicular cancer	5.69e-05	0.000384	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	5.48e-05	0.000369	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STK11—testicular cancer	5.45e-05	0.000367	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KITLG—testicular cancer	5.27e-05	0.000355	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—FGFR3—testicular cancer	5.05e-05	0.000341	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KITLG—testicular cancer	5.04e-05	0.00034	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—HPGDS—testicular cancer	4.99e-05	0.000337	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—FGFR3—testicular cancer	4.84e-05	0.000326	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	4.81e-05	0.000324	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STK11—testicular cancer	4.78e-05	0.000322	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KIT—testicular cancer	4.64e-05	0.000313	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HPGDS—testicular cancer	4.59e-05	0.00031	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HPGDS—testicular cancer	4.55e-05	0.000307	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KIT—testicular cancer	4.44e-05	0.000299	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KITLG—testicular cancer	4.42e-05	0.000298	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—FGFR3—testicular cancer	4.36e-05	0.000294	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—FGFR3—testicular cancer	4.3e-05	0.00029	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KIT—testicular cancer	4e-05	0.00027	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KIT—testicular cancer	3.95e-05	0.000266	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—FGFR3—testicular cancer	3.92e-05	0.000264	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HPGDS—testicular cancer	3.89e-05	0.000262	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	3.75e-05	0.000252	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—STK11—testicular cancer	3.63e-05	0.000245	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KIT—testicular cancer	3.59e-05	0.000242	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KIT—testicular cancer	3.44e-05	0.000232	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—STK11—testicular cancer	3.34e-05	0.000225	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—STK11—testicular cancer	3.31e-05	0.000223	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGFR3—testicular cancer	3.29e-05	0.000222	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KIT—testicular cancer	3.02e-05	0.000204	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—STK11—testicular cancer	2.83e-05	0.000191	CbGpPWpGaD
